Comparability of absolute/percent CD4+ T-lymphocytes completed locally and centrally

Sharyne M. Donfield, Elizabeth M. Mahoney, Margaret A. Maeder, Sarah M. Hawk, Patricia A. Sirois, Sunny K. Pearson, Ilene A. Goldberg, Sharon K. Richard, Kelly A. Baird-Cox, Lauren N Hoel, Valerie A. Cool

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The Hemophilia Growth and Development Study (HGDS) is a multicenter longitudinal study of 333 male children and adolescents with moderate or severe hemophilia, ranging in age from 6 to 19 at entry. Sixty-two percent of the cohort was infected with human immunodeficiency virus (HIV) in the late 1970s and early 1980s through exposure to contaminated clotting factor concentrates. The HGDS has followed this cohort since 1989. HGDS subjects have blood drawn twice each year for t-lymphocyte subsets, with fresh blood shipped overnight to a central laboratory. T-lymphocyte subsets from the same blood draw are often determined locally as well. To evaluate interlaboratory variation, we examined the comparability of pairs of local and central results for CD4+ absolute counts and percents. Ninety-four pairs of absolute counts and 73 pairs of percent CD4+ results were available. We calculated concordance correlation coefficients, which evaluate the agreement between two readings from the sample by measuring the variation from the 45°line through the origin. Absolute counts were square root transformed. Comparability of the pairs was high for both absolute counts and percents (0.93 and 0.92, respectively). Agreement was high whether we determined the CD4+ counts and percents centrally, using fresh samples received the day after the examination (0.95, 0.95), or from specimens that were frozen upon receipt and batched for later testing (0.90, 0.87). We conclude that when a centrally processed CD4+ result is unavailable because of shipping problems or loss of specimens, a study may reasonably accept a CD4+ result completed locally, if validity checks indicate good comparability. In the HGDS, the data provided by the local laboratories were of comparable quality to those provided by the central laboratories. Copyright (C) 1998 Elsevier Science Inc.

Original languageEnglish (US)
Pages (from-to)451-460
Number of pages10
JournalControlled Clinical Trials
Volume19
Issue number5
DOIs
StatePublished - Oct 1998

Fingerprint

Hemophilia A
Growth and Development
T-Lymphocytes
CD4 Lymphocyte Count
Blood Coagulation Factors
Lymphocyte Subsets
T-Lymphocyte Subsets
Multicenter Studies
Longitudinal Studies
Reading
HIV

Keywords

  • CD4+ comparability
  • Central laboratory
  • Interlaboratory variation

ASJC Scopus subject areas

  • Pharmacology

Cite this

Donfield, S. M., Mahoney, E. M., Maeder, M. A., Hawk, S. M., Sirois, P. A., Pearson, S. K., ... Cool, V. A. (1998). Comparability of absolute/percent CD4+ T-lymphocytes completed locally and centrally. Controlled Clinical Trials, 19(5), 451-460. https://doi.org/10.1016/S0197-2456(98)00035-X

Comparability of absolute/percent CD4+ T-lymphocytes completed locally and centrally. / Donfield, Sharyne M.; Mahoney, Elizabeth M.; Maeder, Margaret A.; Hawk, Sarah M.; Sirois, Patricia A.; Pearson, Sunny K.; Goldberg, Ilene A.; Richard, Sharon K.; Baird-Cox, Kelly A.; Hoel, Lauren N; Cool, Valerie A.

In: Controlled Clinical Trials, Vol. 19, No. 5, 10.1998, p. 451-460.

Research output: Contribution to journalArticle

Donfield, SM, Mahoney, EM, Maeder, MA, Hawk, SM, Sirois, PA, Pearson, SK, Goldberg, IA, Richard, SK, Baird-Cox, KA, Hoel, LN & Cool, VA 1998, 'Comparability of absolute/percent CD4+ T-lymphocytes completed locally and centrally', Controlled Clinical Trials, vol. 19, no. 5, pp. 451-460. https://doi.org/10.1016/S0197-2456(98)00035-X
Donfield, Sharyne M. ; Mahoney, Elizabeth M. ; Maeder, Margaret A. ; Hawk, Sarah M. ; Sirois, Patricia A. ; Pearson, Sunny K. ; Goldberg, Ilene A. ; Richard, Sharon K. ; Baird-Cox, Kelly A. ; Hoel, Lauren N ; Cool, Valerie A. / Comparability of absolute/percent CD4+ T-lymphocytes completed locally and centrally. In: Controlled Clinical Trials. 1998 ; Vol. 19, No. 5. pp. 451-460.
@article{42166a74ae7e41e9ac334c57913fb82b,
title = "Comparability of absolute/percent CD4+ T-lymphocytes completed locally and centrally",
abstract = "The Hemophilia Growth and Development Study (HGDS) is a multicenter longitudinal study of 333 male children and adolescents with moderate or severe hemophilia, ranging in age from 6 to 19 at entry. Sixty-two percent of the cohort was infected with human immunodeficiency virus (HIV) in the late 1970s and early 1980s through exposure to contaminated clotting factor concentrates. The HGDS has followed this cohort since 1989. HGDS subjects have blood drawn twice each year for t-lymphocyte subsets, with fresh blood shipped overnight to a central laboratory. T-lymphocyte subsets from the same blood draw are often determined locally as well. To evaluate interlaboratory variation, we examined the comparability of pairs of local and central results for CD4+ absolute counts and percents. Ninety-four pairs of absolute counts and 73 pairs of percent CD4+ results were available. We calculated concordance correlation coefficients, which evaluate the agreement between two readings from the sample by measuring the variation from the 45°line through the origin. Absolute counts were square root transformed. Comparability of the pairs was high for both absolute counts and percents (0.93 and 0.92, respectively). Agreement was high whether we determined the CD4+ counts and percents centrally, using fresh samples received the day after the examination (0.95, 0.95), or from specimens that were frozen upon receipt and batched for later testing (0.90, 0.87). We conclude that when a centrally processed CD4+ result is unavailable because of shipping problems or loss of specimens, a study may reasonably accept a CD4+ result completed locally, if validity checks indicate good comparability. In the HGDS, the data provided by the local laboratories were of comparable quality to those provided by the central laboratories. Copyright (C) 1998 Elsevier Science Inc.",
keywords = "CD4+ comparability, Central laboratory, Interlaboratory variation",
author = "Donfield, {Sharyne M.} and Mahoney, {Elizabeth M.} and Maeder, {Margaret A.} and Hawk, {Sarah M.} and Sirois, {Patricia A.} and Pearson, {Sunny K.} and Goldberg, {Ilene A.} and Richard, {Sharon K.} and Baird-Cox, {Kelly A.} and Hoel, {Lauren N} and Cool, {Valerie A.}",
year = "1998",
month = "10",
doi = "10.1016/S0197-2456(98)00035-X",
language = "English (US)",
volume = "19",
pages = "451--460",
journal = "Controlled Clinical Trials",
issn = "0197-2456",
publisher = "Elsevier BV",
number = "5",

}

TY - JOUR

T1 - Comparability of absolute/percent CD4+ T-lymphocytes completed locally and centrally

AU - Donfield, Sharyne M.

AU - Mahoney, Elizabeth M.

AU - Maeder, Margaret A.

AU - Hawk, Sarah M.

AU - Sirois, Patricia A.

AU - Pearson, Sunny K.

AU - Goldberg, Ilene A.

AU - Richard, Sharon K.

AU - Baird-Cox, Kelly A.

AU - Hoel, Lauren N

AU - Cool, Valerie A.

PY - 1998/10

Y1 - 1998/10

N2 - The Hemophilia Growth and Development Study (HGDS) is a multicenter longitudinal study of 333 male children and adolescents with moderate or severe hemophilia, ranging in age from 6 to 19 at entry. Sixty-two percent of the cohort was infected with human immunodeficiency virus (HIV) in the late 1970s and early 1980s through exposure to contaminated clotting factor concentrates. The HGDS has followed this cohort since 1989. HGDS subjects have blood drawn twice each year for t-lymphocyte subsets, with fresh blood shipped overnight to a central laboratory. T-lymphocyte subsets from the same blood draw are often determined locally as well. To evaluate interlaboratory variation, we examined the comparability of pairs of local and central results for CD4+ absolute counts and percents. Ninety-four pairs of absolute counts and 73 pairs of percent CD4+ results were available. We calculated concordance correlation coefficients, which evaluate the agreement between two readings from the sample by measuring the variation from the 45°line through the origin. Absolute counts were square root transformed. Comparability of the pairs was high for both absolute counts and percents (0.93 and 0.92, respectively). Agreement was high whether we determined the CD4+ counts and percents centrally, using fresh samples received the day after the examination (0.95, 0.95), or from specimens that were frozen upon receipt and batched for later testing (0.90, 0.87). We conclude that when a centrally processed CD4+ result is unavailable because of shipping problems or loss of specimens, a study may reasonably accept a CD4+ result completed locally, if validity checks indicate good comparability. In the HGDS, the data provided by the local laboratories were of comparable quality to those provided by the central laboratories. Copyright (C) 1998 Elsevier Science Inc.

AB - The Hemophilia Growth and Development Study (HGDS) is a multicenter longitudinal study of 333 male children and adolescents with moderate or severe hemophilia, ranging in age from 6 to 19 at entry. Sixty-two percent of the cohort was infected with human immunodeficiency virus (HIV) in the late 1970s and early 1980s through exposure to contaminated clotting factor concentrates. The HGDS has followed this cohort since 1989. HGDS subjects have blood drawn twice each year for t-lymphocyte subsets, with fresh blood shipped overnight to a central laboratory. T-lymphocyte subsets from the same blood draw are often determined locally as well. To evaluate interlaboratory variation, we examined the comparability of pairs of local and central results for CD4+ absolute counts and percents. Ninety-four pairs of absolute counts and 73 pairs of percent CD4+ results were available. We calculated concordance correlation coefficients, which evaluate the agreement between two readings from the sample by measuring the variation from the 45°line through the origin. Absolute counts were square root transformed. Comparability of the pairs was high for both absolute counts and percents (0.93 and 0.92, respectively). Agreement was high whether we determined the CD4+ counts and percents centrally, using fresh samples received the day after the examination (0.95, 0.95), or from specimens that were frozen upon receipt and batched for later testing (0.90, 0.87). We conclude that when a centrally processed CD4+ result is unavailable because of shipping problems or loss of specimens, a study may reasonably accept a CD4+ result completed locally, if validity checks indicate good comparability. In the HGDS, the data provided by the local laboratories were of comparable quality to those provided by the central laboratories. Copyright (C) 1998 Elsevier Science Inc.

KW - CD4+ comparability

KW - Central laboratory

KW - Interlaboratory variation

UR - http://www.scopus.com/inward/record.url?scp=0032189376&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032189376&partnerID=8YFLogxK

U2 - 10.1016/S0197-2456(98)00035-X

DO - 10.1016/S0197-2456(98)00035-X

M3 - Article

C2 - 9741866

AN - SCOPUS:0032189376

VL - 19

SP - 451

EP - 460

JO - Controlled Clinical Trials

JF - Controlled Clinical Trials

SN - 0197-2456

IS - 5

ER -